Showing 1 - 10 of 3,315
In April 2023, the European Commission adopted regulatory proposals introducing a Unitary Supplementary Protection Certificate (SPC) and a centralised assessment procedure for SPCs for medicinal products. This study analyses the potential impacts of these proposals on access to medicines, the...
Persistent link: https://www.econbiz.de/10015277337
In April 2023, the European Commission adopted regulatory proposals introducing a Unitary Supplementary Protection Certificate (SPC) and a centralised assessment procedure for SPCs for medicinal products. This study analyses the potential impacts of these proposals on access to medicines, the...
Persistent link: https://www.econbiz.de/10015277351
In April 2023, the European Commission adopted regulatory proposals introducing a Unitary Supplementary Protection Certificate (SPC) and a centralised assessment procedure for SPCs for medicinal products. This study analyses the potential impacts of these proposals on access to medicines, the...
Persistent link: https://www.econbiz.de/10015280126
Im April 2023 nahm die Kommission Vorschläge zur Einführung eines einheitlichen ergänzenden Schutzzertifikats und eines zentralisierten Prüfverfahrens für ergänzende Schutzzertifikate für Arzneimittel an. In dieser Studie werden die möglichen Auswirkungen dieser Vorschläge auf den...
Persistent link: https://www.econbiz.de/10015274905
Im April 2023 nahm die Kommission Vorschläge zur Einführung eines einheitlichen ergänzenden Schutzzertifikats und eines zentralisierten Prüfverfahrens für ergänzende Schutzzertifikate für Arzneimittel an. In dieser Studie werden die möglichen Auswirkungen dieser Vorschläge auf den...
Persistent link: https://www.econbiz.de/10015274936
There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...
Persistent link: https://www.econbiz.de/10015276088
There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...
Persistent link: https://www.econbiz.de/10015276135
Persistent link: https://www.econbiz.de/10012163302
This study provides an overview of EU funding and agencies in the field of migration, asylum and integration. It begins with a brief assessment of their effectiveness and efficiency before examining whether the design of management, budgeting and control systems is effective in preventing the...
Persistent link: https://www.econbiz.de/10015298033
This study provides an overview of EU funding and agencies in the field of migration, asylum and integration. It begins with a brief assessment of their effectiveness and efficiency before examining whether the design of management, budgeting and control systems is effective in preventing the...
Persistent link: https://www.econbiz.de/10015298041